PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

XCounter AB Bags the 2007 Frost & Sullivan Entrepreneurial Company Award - XCounter AB Bags the 2007 Frost & Sullivan Entrepreneurial company Award in the European Mammography Systems Market
XCounter AB Bags the 2007 Frost & Sullivan Entrepreneurial Company Award


NewswireToday - /newswire/ - London, United Kingdom, 2007/03/21 - XCounter AB Bags the 2007 Frost & Sullivan Entrepreneurial company Award in the European Mammography Systems Market.

Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


This Award is presented in recognition of the company’s successful XCT technology and its products which include the XC Mammo-3T, XC MP -3T for general body imaging, as well as the Cardio -3T and XC Cardio -4T for preventive cardiac imaging.

An invention and development house for X-ray companies, XCounter comprises 55 highly qualified researchers in the field of space research and radiation instrumentation development. Their expertise was used to transform the company’s existing technology into the XCT technology through the development of commercial medical imaging products.

“XCounter is set to launch a 3D mammography digital system based on its unique proprietary technology in 2007-2008,” notes Frost & Sullivan Research Analyst Ms. Divya B. “If launched at the right time, the product will enable the company to take advantage of the growing digital mammography market in Europe.”

Using the XCT technology, a 2D mammography system was successfully developed and tested in 2002-2003. In 2004, XCounter commenced the development of the XC Mammo –3T, a 3D product for digital mammography screening. This 3D mammography system is currently being tested on patients. The company pronounces that the tests confirm the technology’s ability to produce high quality images at a low radiation dose to the patient.

XCounter’s unique and proprietary technology, the XCT -3T, is said to have several major advantages over competing technologies. The XC Mammo -3T system provides for the production of high quality 3D images at low levels of radiation dose to the patient, less compression of the breast and reduced patient movement blurring, all at competitive production costs. The system also enables fewer physical recalls of patients and results in a faster workflow.

“XCounter’s business model is based on the concept of co-opetition,” says Ms. Divya. “The commercialisation strategy of the company is to enter into licensing/development agreements with leading global X-ray systems marketing and distribution companies, thus leveraging their established distribution network.”

Currently, the prototype is ready and the technology is undergoing a second patient study. With the initial launch in Europe, the product will eventually compete with film-based and digital medical X-ray imaging machines in the global market.

“Demonstrating true entrepreneurship, XCounter has embarked on a business venture in response to identified opportunities,” remarks Ms. Divya. “The company believes that it can initially capture one-third market share of the 3D digital mammography market and has taken prudent risks, assessing the needs of the market.”

The Frost & Sullivan Award for Entrepreneurial Company is presented each year to a small company that demonstrated superior entrepreneurial ability in its industry during the research period. This Award signifies the company's identification of a unique and revolutionary product solution with significant market potential. Additionally, the Award certifies that the company's marketing strategy is sound and poised for success.

Frost & Sullivan Best Practices Awards recognise companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.

About Frost & Sullivan
Frost & Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. The company's industry expertise integrates growth consulting, growth partnership services, and corporate management training to identify and develop opportunities. Frost & Sullivan serves an extensive clientele that includes Global 1000 companies, emerging companies, and the investment community by providing comprehensive industry coverage that reflects a unique global perspective and combines ongoing analysis of markets, technologies, econometrics, and demographics.

About XCounter
XCounter is the innovation and development house for the leading X-ray companies. XCounter offers ready-to-market imaging systems based on unique 3D technologies. The company was founded in 1997 by researchers with NASA and CERN experience in space research. It is listed on the London Stock Exchange's AIM market. XCounter is based in Stockholm, Sweden.

XCounter’s unique and proprietary technology for 3-dimensional X-ray imaging, XCT -3T, has a number of advantages over competing technologies. XCT -3T enables fast acquisition of high resolution 3D images, at low levels of radiation dose. This means more predictable diagnosis as well lower risks for the patients when compared to existing imaging techniques.

XCounter currently has four product platforms in development based on XCT -3T, XCounter’s unique technology. The first is XC Mammo -3T, the only system originally designed for 3D breast cancer screening. Secondly the XC MP -3T for general body imaging, which is introducing low dose 3D imaging in to general X-ray imaging and preventive cancer screening.

XCounter also develops two platforms for preventive cardiac imaging. XC Cardio -3T for functional imaging of the heart which will have the capability of imaging the perfusion of blood through the heart muscle, leakage through the valves and blood flow through coronary arteries in different phases of the heart cycle. These capabilities will give information enabling the doctor to take medical measures before any serious complications occur.

The heart is a very dynamic organ, and many of the heart diseases are best visualised dynamically and our product platform XC Cardio -4T introduces a totally new dimension by imaging 3D movies of the beating heart. We believe XC Cardio -4T is a solution to a medical need, which none of the leading X-ray companies to date has been able to satisfactorily address.

The XCT -3T based product platforms described above target the major part of the US$7 billion digital X-ray system market, and have the potential to expand the market through the introduction of novel low-dose screening applications.

For further information, please contact:
XCounter AB (publ.)
Dr Tom Francke, Chief Executive Officer, T: +46 8622 2300

Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


Written by / Agency / Source: Frost & Sullivan


Availability: All Regions (Including Int'l)


Traffic Booster: [/] Quick Newswire Today Visibility Checker


Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

# # #
  Your Banner Ad showing on ALL
Medical Services/Equipment articles,
CATCH Visitors via Your Competitors Announcements!

XCounter AB Bags the 2007 Frost & Sullivan Entrepreneurial Company Award

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

Publisher Contact: Sandra Holze 
+44 20 7915 7866
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Medical Services/Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Read Latest Articles From Frost & Sullivan / Company Profile

Read Medical Services/Equipment Most Recent Related Newswires:

Frost & Sullivan Recognizes Ventec Life Systems for New Product Innovation - Game-changing, Modular Respiratory System, VOCSN
BD Expands Genomics Portfolio with New Single Cell Platform for RNA Expression Analysis
GE Healthcare Advances the Delivery of Cell Therapies with New Thawing Technology
Ansell Limited Announces the Closing of the Sale of its Sexual Wellness Business
PQ Bypass Earns Frost & Sullivan’s European Technology Innovation Award for its Proprietary DETOUR System for Percutaneous Bypass
Curaçao EMS Uses ZOLL Autopulse to Save Tourist in Sudden Cardiac Arrest
ZOLL to Showcase Expanded Portfolio of AEDs at Caravan Salon 2017
MDxHealth Announces Service Agreement with Kaiser Southern California Permanente Medical Group
Frost & Sullivan Lauds CytoSorbents for Leading the Critical Care Immunotherapy Segment with its Novel Blood Purification Solution, CytoSorb®
MVZ Dr. Stein & Kollegen First German Medical Laboratory to Offer the SelectMDx for Prostate Cancer Test
Datalogic Announces New Healthcare Memor X3 HC Mobile Computer
Neuronix Ltd Announces the First Group of Mild to Moderate Alzheimer Patients to be Successfully Treated by The NeuroAD™ Therapy System
SelectMDx to be Distributed Across Middle East by IPS Genomix
GE Healthcare Partners with Oritain to Introduce Independent Test to Confirm Country of Origin of Fetal Bovine Serum
Saebo, Inc. Awarded Patent for Low-Profile Stroke Recovery Glove

Boost Your Social Network
& Crowdfunding Campaigns

NewswireToday Celebrates 10 Years in Business



Visit  NAKIVO, Inc.

  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (